菜单
Telephone sharing button Contact Us linkedin sharing button LinkedIn wechat sharing button YouTube wechat sharing button Twitter mailbox sharing button info@wuxibiologics.com
arrow_left sharing button
arrow_right sharing button

Poster modified on 13/12/2023

Optimizing Bispecific Antibody Production: Strategies for Improved Purity and Yield
Gaozhan Zhang, Li Zhang, Dawei Zhang, Mengjie Lu, Zhumei Feng, Jiansheng Wu
WuXi Biologics, NO.240 Hedan Road, Pudong New District, Shanghai, China

Bispecific antibodies (BsAbs) are a rapidly evolving and promising category of biotherapeutics. Unlike monoclonal antibodies, the production of bsAbs presents significant challenges in terms of quantity, quality, and stability, which could potentially limit their wider adoption in clinical applications. At WuXi Biologics, our Protein Sciences (PS) Department has developed integrated strategies to overcome these challenges in bsAb production.

 

This scientific poster was originally presented during the 2023 AET conference

Discuss This Poster

To discuss the data in this poster, please complete the form on the following page to connect with our experts.

Connect with our Experts